physIQ

InCarda, PhysIQ and Syneos team for phase 3 flecainide study

August 31, 2022

Originally published in Fierce Biotech

Life Sciences Media Mentions
Read More

Syneos joins with physIQ, InCarda on atrial fibrillation study

August 30, 2022

Originally published in Outsourcing Pharma

Life Sciences Media Mentions
Read More

People on the Move: Michael Neeb

August 29, 2022

Originally published in Crain's Chicago Business

Corporate Media Mentions
Read More

physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health

August 24, 2022

Originally published in Applied Clinical Trials

Life Sciences Media Mentions
Read More

physIQ, InCarda Therapeutics to collaborate on AFib treatment tech

August 24, 2022

Originally published in MassDevice

Life Sciences Media Mentions
Read More

physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health to Accelerate Innovative Phase III Study in Patients with Atrial Fibrillation

August 24, 2022
Life Sciences Press Releases
Read More

Esteemed Healthcare Executive, Michael Neeb, Named physIQ Special Advisor

August 10, 2022
Corporate Press Releases
Read More

Crain’s Chicago Business' Notable Executives in HR and Diversity, Equity and Inclusion

August 5, 2022

Originally published in Crain's Chicago

Corporate Media Mentions
Read More

Rethinking the Changing Role of the CRO

June 3, 2022

Originally published in Contract Pharma

Life Sciences Media Mentions
Read More

physIQ hires a pair of commercial execs

May 16, 2022

Originally published in Medical Marketing and Media

Corporate Media Mentions
Read More
Prev 1 2 3 4 5 Next